Management of Epidermolysis Bullosa Acquisita
Copyright policy )Management of Epidermolysis Bullosa Acquisita
Epidermolysis bullosa acquisita is a rare and debilitating autoimmune mucocutaneous blistering disease caused by autoantibodies directed against type VII collagen or anchoring fibrils in the subepidermal basement membrane zone. Treatment is quite challenging because this disease can be recalcitrant to multiple modalities. This article discusses the current management of this disease.
- UNSW Sydney Australia
- St George's Hospital United Kingdom
- St George Hospital Australia
- St George’s University Hospitals NHS Foundation Trust United Kingdom
Male, Collagen Type VII, Immunoglobulins, Intravenous, Plasmapheresis, Epidermolysis Bullosa Acquisita, Mycophenolic Acid, Autoimmune Diseases, Sulfasalazine, Antibodies, Monoclonal, Murine-Derived, Photochemotherapy, Sulfapyridine, Chronic Disease, Cyclosporine, Humans, Dermatologic Agents, Colchicine, Rituximab, Dapsone, Immunosuppressive Agents, Autoantibodies
Male, Collagen Type VII, Immunoglobulins, Intravenous, Plasmapheresis, Epidermolysis Bullosa Acquisita, Mycophenolic Acid, Autoimmune Diseases, Sulfasalazine, Antibodies, Monoclonal, Murine-Derived, Photochemotherapy, Sulfapyridine, Chronic Disease, Cyclosporine, Humans, Dermatologic Agents, Colchicine, Rituximab, Dapsone, Immunosuppressive Agents, Autoantibodies
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).16 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 10% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
Citations provided by BIP!Popularity provided by BIP!